Royal Bank of Canada’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$79.8M Sell
630,539
-133,816
-18% -$16.9M 0.01% 663
2025
Q1
$97.8M Sell
764,355
-441,817
-37% -$56.5M 0.02% 521
2024
Q4
$159M Sell
1,206,172
-266,253
-18% -$35.2M 0.03% 391
2024
Q3
$214M Buy
1,472,425
+194,889
+15% +$28.4M 0.04% 319
2024
Q2
$175M Sell
1,277,536
-39,540
-3% -$5.43M 0.04% 337
2024
Q1
$181M Buy
1,317,076
+157,418
+14% +$21.6M 0.04% 329
2023
Q4
$158M Sell
1,159,658
-42,499
-4% -$5.77M 0.04% 355
2023
Q3
$147M Sell
1,202,157
-96,775
-7% -$11.8M 0.04% 342
2023
Q2
$165M Sell
1,298,932
-523,930
-29% -$66.5M 0.04% 327
2023
Q1
$235M Sell
1,822,862
-7,453
-0.4% -$963K 0.07% 245
2022
Q4
$240M Buy
1,830,315
+124,034
+7% +$16.3M 0.07% 232
2022
Q3
$200M Buy
1,706,281
+7,013
+0.4% +$820K 0.06% 245
2022
Q2
$200M Buy
1,699,268
+421,632
+33% +$49.6M 0.06% 250
2022
Q1
$166M Sell
1,277,636
-62,619
-5% -$8.16M 0.04% 313
2021
Q4
$205M Buy
1,340,255
+11,651
+0.9% +$1.78M 0.05% 289
2021
Q3
$215M Buy
1,328,604
+293,379
+28% +$47.4M 0.06% 264
2021
Q2
$169M Sell
1,035,225
-165,836
-14% -$27.1M 0.05% 320
2021
Q1
$181M Sell
1,201,061
-74,504
-6% -$11.2M 0.05% 285
2020
Q4
$193M Buy
1,275,565
+115,320
+10% +$17.5M 0.06% 253
2020
Q3
$157M Sell
1,160,245
-77,523
-6% -$10.5M 0.06% 246
2020
Q2
$169M Buy
1,237,768
+623,560
+102% +$85.2M 0.07% 213
2020
Q1
$66.2M Sell
614,208
-15,666
-2% -$1.69M 0.03% 369
2019
Q4
$75.9M Sell
629,874
-63,845
-9% -$7.69M 0.03% 407
2019
Q3
$69M Sell
693,719
-52,340
-7% -$5.21M 0.03% 412
2019
Q2
$81.4M Sell
746,059
-48,697
-6% -$5.31M 0.03% 359
2019
Q1
$88.9M Buy
794,756
+23,852
+3% +$2.67M 0.04% 321
2018
Q4
$74.3M Sell
770,904
-773
-0.1% -$74.5K 0.04% 336
2018
Q3
$94.1M Sell
771,677
-39,217
-5% -$4.78M 0.04% 323
2018
Q2
$89.1M Sell
810,894
-87,586
-10% -$9.62M 0.04% 310
2018
Q1
$95.9M Buy
898,480
+27,047
+3% +$2.89M 0.04% 306
2017
Q4
$93M Sell
871,433
-288,100
-25% -$30.8M 0.04% 312
2017
Q3
$129M Buy
1,159,533
+20,025
+2% +$2.23M 0.06% 234
2017
Q2
$118M Sell
1,139,508
-154,389
-12% -$16M 0.06% 240
2017
Q1
$126M Buy
1,293,897
+259,668
+25% +$25.4M 0.07% 212
2016
Q4
$91.5M Buy
1,034,229
+381,660
+58% +$33.8M 0.05% 273
2016
Q3
$63M Buy
652,569
+138,615
+27% +$13.4M 0.04% 353
2016
Q2
$44.1M Buy
513,954
+32,724
+7% +$2.81M 0.03% 453
2016
Q1
$41.8M Sell
481,230
-65,451
-12% -$5.69M 0.03% 461
2015
Q4
$61.7M Buy
546,681
+39,849
+8% +$4.49M 0.04% 325
2015
Q3
$51.2M Sell
506,832
-10,731
-2% -$1.08M 0.04% 306
2015
Q2
$63.7M Buy
517,563
+45,456
+10% +$5.59M 0.04% 286
2015
Q1
$54M Buy
472,107
+25,563
+6% +$2.93M 0.04% 330
2014
Q4
$45.2M Sell
446,544
-18,477
-4% -$1.87M 0.03% 384
2014
Q3
$42.4M Buy
465,021
+122,604
+36% +$11.2M 0.03% 368
2014
Q2
$29.3M Buy
342,417
+54,912
+19% +$4.7M 0.02% 517
2014
Q1
$22.7M Sell
287,505
-76,353
-21% -$6.02M 0.02% 613
2013
Q4
$27.5M Buy
363,858
+139,299
+62% +$10.5M 0.02% 510
2013
Q3
$15.7M Buy
224,559
+41,820
+23% +$2.92M 0.01% 708
2013
Q2
$10.6M Buy
+182,739
New +$10.6M 0.01% 823